Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1984-02-16
1987-07-21
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 93, 4351721, 4351723, 435253, A61K 39102, A61K 3902, C12N 1500, C12N 120
Patent
active
046817620
ABSTRACT:
The present invention relates to a vaccine composition for the prevention of infectious diseases comprising an immunogenically-effective amount of a genetically attenuated and stable avirulent bacterial strain derived from a virulent bacterial strain by introducing into said virulent strain by genetic transfer and recombination at least two mutations of the same phenotype which renders said virulent strain avirulent, while permitting said avirulent strain to retain immunogenicity, together with an inert pharmacologically acceptable carrier. It also relates to a method for preparing the vaccine.
REFERENCES:
patent: 3856935 (1972-12-01), Germanier
patent: 4169886 (1979-10-01), Hertman et al.
patent: 4264737 (1981-04-01), Murphy
patent: 4328209 (1982-05-01), Finkelstein et al.
Bellanti Joseph A.
Hooke Anne M.
Oeschger Max P.
Hazel Blondel
Research Corporation
LandOfFree
Genetically attenuated bacterial vaccines with multiple mutation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically attenuated bacterial vaccines with multiple mutation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically attenuated bacterial vaccines with multiple mutation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206467